| ID,author,year,cancerType,cellLine,time,coumarin,coumarinDose,viability,viabilitySD,viabilityN,control,controlSD,controlN | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,16.7,93.61,6.39,3,85.81,2.13,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,33.4,85.81,2.13,3,85.81,2.13,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,66.8,78.95,8.04,3,85.81,2.13,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,24,Auraptene,133.6,52,11.35,3,85.81,2.13,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,16.7,92.67,4.49,3,96.69,3.31,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,33.4,79.9,5.2,3,96.69,3.31,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,66.8,53.19,4.49,3,96.69,3.31,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,48,Auraptene,133.6,37.58,5.91,3,96.69,3.31,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,16.7,97.87,1.42,3,92.9,2.84,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,33.4,91.48,6.62,3,92.9,2.84,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,66.8,60.04,14.19,3,92.9,2.84,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,72,Auraptene,133.6,44.2,5.44,3,92.9,2.84,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,16.7,84.86,5.21,3,90.7,2.12,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,33.4,69.97,4.26,3,90.7,2.12,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,66.8,65.01,6.43,3,90.7,2.12,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,96,Auraptene,133.6,43.26,3.54,3,90.7,2.12,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,16.7,74.94,11.34,3,92.9,7.1,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,33.4,72.1,10.16,3,92.9,7.1,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,66.8,69.97,6.43,3,92.9,7.1,3 | |
| 6,Movaffagh et al.,2021,Gastric,MKN-45,120,Auraptene,133.6,41.13,5.67,3,92.9,7.1,3 | |
| 8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,31.49,50,5.83,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,47.93,50,5.83,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,3.13,88.38,6.36,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,6.25,82.32,2.38,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,12.5,71.21,5.57,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,25,55.34,6.1,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,50,41.59,3.44,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Ovarian,A2780,24,Auraptene,100,22.53,0.79,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,3.13,88.35,11.65,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,6.25,85.44,7.41,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,12.5,72.25,19.84,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,25,69.04,5.03,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,50,64.28,9.26,3,100,3.36,3 | |
| 8,Jamialahmadi et al.,2018,Cervical,Hela,24,Auraptene,100,18.78,3.45,3,100,3.36,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,5,93.33,8.23,3,95.68,3.13,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,10,94.5,4.7,3,95.68,3.13,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,20,92.15,6.66,3,95.68,3.13,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,40,85.88,4.7,3,95.68,3.13,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,48,Auraptene,80,65.88,6.27,3,95.68,3.13,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,5,93.72,3.92,3,88.23,8.62,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,10,85.88,7.84,3,88.23,8.62,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,20,83.13,7.05,3,88.23,8.62,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,40,76.86,10.19,3,88.23,8.62,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,72,Auraptene,80,64.31,8.23,3,88.23,8.62,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,5,92.94,7.84,3,81.56,8.23,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,10,85.49,10.19,3,81.56,8.23,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,20,81.56,3.13,3,81.56,8.23,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,40,78.43,6.27,3,81.56,8.23,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,96,Auraptene,80,49.41,1.96,3,81.56,8.23,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,5,86.66,3.92,3,80.78,6.66,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,10,81.17,8.62,3,80.78,6.66,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,20,77.64,3.13,3,80.78,6.66,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,40,73.72,5.88,3,80.78,6.66,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,120,Auraptene,80,42.35,4.31,3,80.78,6.66,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,5,79.6,4.7,3,77.25,6.66,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,10,76.47,8.23,3,77.25,6.66,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,20,73.72,3.13,3,77.25,6.66,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,40,70.58,5.09,3,77.25,6.66,3 | |
| 42,Abolhassani et al.,2023,Prostate,PC3,144,Auraptene,80,34.9,5.88,3,77.25,6.66,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,16.7,99.25,4.32,3,99.38,3.11,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,33.5,100.37,2.47,3,99.38,3.11,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,67,99.04,3.7,3,99.38,3.11,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,24,Auraptene,134,97.71,3.09,3,99.38,3.11,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,16.7,103.91,2.47,3,103.43,2.47,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,33.5,96.98,3.09,3,103.43,2.47,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,67,84.53,3.7,3,103.43,2.47,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,48,Auraptene,134,76.37,4.34,3,103.43,2.47,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,16.7,105.6,9.87,3,110.65,8,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,33.5,102.49,10.49,3,110.65,8,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,67,87.02,4.32,3,110.65,8,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,72,Auraptene,134,75.27,8.02,3,110.65,8,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,16.7,80.24,7.95,3,82.62,6.41,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,33.5,78.18,6.43,3,82.62,6.41,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,67,62.05,4.28,3,82.62,6.41,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,96,Auraptene,134,45.63,6.42,3,82.62,6.41,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,16.7,91.8,3.67,3,91.46,3.06,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,33.5,82.35,1.83,3,91.46,3.06,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,67,60.04,9.48,3,91.46,3.06,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,120,Auraptene,134,47.54,6.12,3,91.46,3.06,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,16.7,88.86,1.83,3,88.2,3.67,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,33.5,78.25,6.41,3,88.2,3.67,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,67,56.34,7.95,3,88.2,3.67,3 | |
| 44,Bagheri et al.,2022,Leukemia/Lymphoma,MT-2,144,Auraptene,134,40.24,1.83,3,88.2,3.67,3 | |
| 46,Afshari et al.,2019,Glioblastoma,U87,8,Auraptene,167.6,70.16,2.76,3,100,1.65,3 | |
| 46,Afshari et al.,2019,Glioblastoma,U87,8,Auraptene,335.2,51.93,3.31,3,100,1.65,3 | |
| 46,Afshari et al.,2019,Glioblastoma,U87,24,Auraptene,167.6,57.91,3.34,3,100,2.09,3 | |
| 46,Afshari et al.,2019,Glioblastoma,U87,24,Auraptene,335.2,42.5,2.91,3,100,2.09,3 | |
| 47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,2.5,90.94,4.53,3,99.62,12.45,3 | |
| 47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,5,86.41,4.53,3,99.62,12.45,3 | |
| 47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,10,75.09,7.55,3,99.62,12.45,3 | |
| 47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,20,55.09,16.6,3,99.62,12.45,3 | |
| 47,Epifano et al.,2013,Colon,HT-29,72,Auraptene,40,28.3,2.26,3,99.62,12.45,3 | |
| 47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,2.5,86.41,9.43,3,100,9.05,3 | |
| 47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,5,84.9,19.62,3,100,9.05,3 | |
| 47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,10,70.18,19.63,3,100,9.05,3 | |
| 47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,20,56.6,3.77,3,100,9.05,3 | |
| 47,Epifano et al.,2013,Colon,HT-116,72,Auraptene,40,45.66,17.35,3,100,9.05,3 | |
| 48,Moon et al.,2015,Gastric,AGS,48,Auraptene,12.5,92.84,13.58,3,100,2.91,3 | |
| 48,Moon et al.,2015,Gastric,AGS,48,Auraptene,25,80.73,9.91,3,100,2.91,3 | |
| 48,Moon et al.,2015,Gastric,AGS,48,Auraptene,50,48.44,6.23,3,100,2.91,3 | |
| 48,Moon et al.,2015,Gastric,AGS,48,Auraptene,100,42.2,4.03,3,100,2.91,3 | |
| 48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,12.5,108.62,21.65,3,100,6.6,3 | |
| 48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,25,109.35,13.21,3,100,6.6,3 | |
| 48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,50,67.88,14.68,3,100,6.6,3 | |
| 48,Moon et al.,2015,Gastric,MKN-45,48,Auraptene,100,35.59,3.67,3,100,6.6,3 | |
| 48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,12.5,66.42,15.78,3,100,3.67,3 | |
| 48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,25,44.77,10.27,3,100,3.67,3 | |
| 48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,50,29.35,1.47,3,100,3.67,3 | |
| 48,Moon et al.,2015,Gastric,SNU-1,48,Auraptene,100,29.72,1.1,3,100,3.67,3 | |
| 48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,12.5,86.97,3.3,3,100,8.07,3 | |
| 48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,25,84.4,4.4,3,100,8.07,3 | |
| 48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,50,48.44,3.67,3,100,8.07,3 | |
| 48,Moon et al.,2015,Gastric,SNU-16,48,Auraptene,100,44.03,4.41,3,100,8.07,3 | |
| 49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,1,89.04,6.18,3,100,9.01,3 | |
| 49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,2,98.87,10.68,3,100,9.01,3 | |
| 49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,5,100.28,10.67,3,100,9.01,3 | |
| 49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,10,68.25,8.99,3,100,9.01,3 | |
| 49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,15,25.28,5.33,3,100,9.01,3 | |
| 49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,20,18.82,3.93,3,100,9.01,3 | |
| 49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,25,15.73,1.96,3,100,9.01,3 | |
| 49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,30,15.16,2.53,3,100,9.01,3 | |
| 49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,40,16.57,1.96,3,100,9.01,3 | |
| 49,Krishnan et al.,2009,Breast,MDA-MB231,24,Auraptene,50,17.97,2.53,3,100,9.01,3 | |
| 49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,1,107.26,4.93,3,100,3.36,3 | |
| 49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,2,106.84,6.17,3,100,3.36,3 | |
| 49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,5,95.75,4.11,3,100,3.36,3 | |
| 49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,10,96.98,6.99,3,100,3.36,3 | |
| 49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,15,76.84,4.11,3,100,3.36,3 | |
| 49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,20,74.79,5.34,3,100,3.36,3 | |
| 49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,25,65.34,5.75,3,100,3.36,3 | |
| 49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,30,56.71,5.34,3,100,3.36,3 | |
| 49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,40,51.78,4.52,3,100,3.36,3 | |
| 49,Krishnan et al.,2009,Breast,MCF-7,24,Auraptene,50,51.36,5.35,3,100,3.36,3 | |
| 51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,48,Auraptene,10,98.62,1.83,3,99.9,1.76,3 | |
| 51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,48,Auraptene,20,100,4.3,3,99.9,1.76,3 | |
| 51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,10,97.8,1.74,3,99.4,1.51,3 | |
| 51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,20,95.7,4.3,3,99.4,1.51,3 | |
| 51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,72,Auraptene,40,79.2,10.7,3,99.4,1.51,3 | |
| 51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,10,81.2,15.58,3,98.9,2.01,3 | |
| 51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,20,87.3,3.52,3,98.9,2.01,3 | |
| 51,Goodarzi et al.,2021,Leukemia/Lymphoma,MT-2,96,Auraptene,40,76,11.61,3,98.9,2.01,3 | |
| 52,Li et al.,2013,Breast,T47D,48,Auraptene,1,90.2,2.45,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,T47D,48,Auraptene,3,88.73,4.9,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,T47D,48,Auraptene,10,78.93,3.93,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,T47D,48,Auraptene,30,52.46,2.46,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,T47D,144,Auraptene,1,87.09,1.44,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,T47D,144,Auraptene,3,84.22,1.44,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,T47D,144,Auraptene,10,57.9,2.87,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,T47D,144,Auraptene,30,19.14,1.43,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,1,99.53,3.3,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,3,100,2.8,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,10,98.12,2.82,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,MDA-MB231,48,Auraptene,30,87.74,1.89,3,100,3.36,3 | |
| 52,Li et al.,2013,Breast,MDA-MB231,144,Auraptene,30,71,0.5,3,100,3.36,3 | |
| 59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,61.3,50,3.65,3,100,3.36,3 | |
| 59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,103.8,75,4.79,3,100,3.36,3 | |
| 59,Charmforoshan et al.,2019,Breast,MCF-7,48,Auraptene,207.7,49.24,2.52,3,100,3.36,3 | |
| 60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,12.25,81.44,6.09,6,100,3.36,6 | |
| 60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,25,75.34,5.54,6,100,3.36,6 | |
| 60,Epifano et al.,2023,Neuroblastoma,SHSY-5Y,24,Auraptene,50,62.04,5.81,6,100,3.36,6 | |
| 61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,70,50,6.82,2,100,3.36,2 | |
| 61,Gkionis et al.,2021,Breast,MDA-MB231,48,Auraptene,60,50,6.82,2,100,3.36,2 | |
| 61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,0.1,103.26,12.76,2,100,3.36,2 | |
| 61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,1,99.11,7.12,2,100,3.36,2 | |
| 61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,10,89.91,6.23,2,100,3.36,2 | |
| 61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,50,70.91,4.75,2,100,3.36,2 | |
| 61,Gkionis et al.,2021,Breast,MCF-7,48,Auraptene,100,26.11,6.82,2,100,3.36,2 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,12.5,105.25,3.94,3,99.9,1.97,3 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,25,106.37,8.45,3,99.9,1.97,3 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,50,84.99,5.34,3,99.9,1.97,3 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,24,Auraptene,100,75.42,2.53,3,99.9,1.97,3 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,12.5,80.44,1.59,3,99.82,2.39,3 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,25,61.85,1.86,3,99.82,2.39,3 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,50,50.7,1.86,3,99.82,2.39,3 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,48,Auraptene,100,38.76,1.59,3,99.82,2.39,3 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,12.5,76.01,1.75,3,100,2.04,3 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,25,59.12,2.91,3,100,2.04,3 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,50,46.89,3.2,3,100,2.04,3 | |
| 62,Jalilzade et al.,2020,Colon,HT-29,72,Auraptene,100,42.52,5.53,3,100,2.04,3 | |
| 63,Lee et al.,2017,Prostate,PC3,24,Auraptene,15,99.68,2.02,3,100,3.36,3 | |
| 63,Lee et al.,2017,Prostate,PC3,24,Auraptene,30,80.42,7.84,3,100,3.36,3 | |
| 63,Lee et al.,2017,Prostate,PC3,24,Auraptene,60,63.39,3.36,3,100,3.36,3 | |
| 63,Lee et al.,2017,Prostate,PC3,24,Auraptene,90,60.48,2.91,3,100,3.36,3 | |
| 63,Lee et al.,2017,Prostate,PC3,24,Auraptene,120,43.68,2.46,3,100,3.36,3 | |
| 63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,15,87.81,3.59,3,100,2.24,3 | |
| 63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,30,79.3,1.57,3,100,2.24,3 | |
| 63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,60,70.34,1.56,3,100,2.24,3 | |
| 63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,90,62.72,3.36,3,100,2.24,3 | |
| 63,Lee et al.,2017,Prostate,LNCaP,24,Auraptene,120,57.34,2.24,3,100,2.24,3 | |
| 63,Lee et al.,2017,Prostate,DU145,24,Auraptene,15,72.04,2.31,3,100,2.8,3 | |
| 63,Lee et al.,2017,Prostate,DU145,24,Auraptene,30,60.21,3.58,3,100,2.8,3 | |
| 63,Lee et al.,2017,Prostate,DU145,24,Auraptene,60,56.45,2.33,3,100,2.8,3 | |
| 63,Lee et al.,2017,Prostate,DU145,24,Auraptene,90,41.03,2.28,3,100,2.8,3 | |
| 63,Lee et al.,2017,Prostate,DU145,24,Auraptene,120,33.15,5.02,3,100,2.8,3 | |
| 64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,40,89.38,11.02,3,100,3.36,3 | |
| 64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,80,80.81,2.04,3,100,3.36,3 | |
| 64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,160,77.55,2.45,3,100,3.36,3 | |
| 64,Izadi et al.,2023,Glioblastoma,U87,24,Auraptene,330,46.53,2.45,3,100,3.36,3 | |
| 66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,6.25,94.44,2.96,3,100,3.36,3 | |
| 66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,12.5,92.59,1.48,3,100,3.36,3 | |
| 66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,25,87.03,3.34,3,100,3.36,3 | |
| 66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,50,84.07,2.59,3,100,3.36,3 | |
| 66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,100,58.14,2.6,3,100,3.36,3 | |
| 66,Shiran et al.,2021,Breast,MDA-MB231,24,Auraptene,200,41.48,1.48,3,100,3.36,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,24,Umbelliprenin,10,91,1.4,3,94.68,1.69,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,24,Umbelliprenin,20,80.27,1.97,3,94.68,1.69,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,24,Umbelliprenin,50,68.7,2.25,3,94.68,1.69,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,24,Umbelliprenin,100,51.49,8.16,3,94.68,1.69,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,24,Umbelliprenin,200,9.22,1.12,3,94.68,1.69,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,48,Umbelliprenin,10,86.31,1.97,3,97.31,1.97,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,48,Umbelliprenin,20,76.97,5.35,3,97.31,1.97,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,48,Umbelliprenin,50,64.56,4.22,3,97.31,1.97,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,48,Umbelliprenin,100,18.63,1.12,3,97.31,1.97,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,48,Umbelliprenin,200,9.13,1.4,3,97.31,1.97,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,72,Umbelliprenin,10,88.65,1.7,3,96.28,2.81,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,72,Umbelliprenin,20,79.33,4.5,3,96.28,2.81,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,72,Umbelliprenin,50,57.06,10.99,3,96.28,2.81,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,72,Umbelliprenin,100,19.56,1.4,3,96.28,2.81,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,A549,72,Umbelliprenin,200,10.82,2.53,3,96.28,2.81,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,24,Umbelliprenin,10,94.82,2.01,3,93.1,0.86,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,24,Umbelliprenin,20,89.36,4.2,3,93.1,0.86,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,24,Umbelliprenin,50,81.69,3.44,3,93.1,0.86,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,24,Umbelliprenin,100,54.59,12.93,3,93.1,0.86,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,24,Umbelliprenin,200,32.18,6.32,3,93.1,0.86,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,48,Umbelliprenin,10,90.8,3.16,3,91.66,2.29,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,48,Umbelliprenin,20,87.06,2.58,3,91.66,2.29,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,48,Umbelliprenin,50,66.09,2.01,3,91.66,2.29,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,48,Umbelliprenin,100,31.6,10.91,3,91.66,2.29,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,48,Umbelliprenin,200,10.91,4.31,3,91.66,2.29,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,72,Umbelliprenin,10,86.2,5.17,3,91.95,2.58,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,72,Umbelliprenin,20,79.02,6.32,3,91.95,2.58,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,72,Umbelliprenin,50,72.12,5.45,3,91.95,2.58,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,72,Umbelliprenin,100,27.58,11.78,3,91.95,2.58,3 | |
| 38,Khaghanzadeh et al.,2012,Lung,QU-DB,72,Umbelliprenin,200,5.74,2.29,3,91.95,2.58,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,36.4,50,3.615,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,33.6,50,3.615,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,37.1,50,3.615,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,40.8,50,3.615,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,36.04,50,3.615,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,55.8,50,3.615,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,51.9,50,3.615,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,37.9,50,3.615,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,43.6,50,3.615,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,8.1,98.85,3.43,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,16.3,98.28,4,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,32.7,89.92,3.04,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,68.2,71.29,3.42,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,136.4,29.08,2.85,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,24,Umbelliprenin,272.8,15.39,3.05,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,8.1,99.23,3.05,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,16.3,89.92,3.61,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,32.7,92.38,3.62,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,68.2,64.06,4,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,136.4,25.28,2.85,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,48,Umbelliprenin,272.8,18.63,2.85,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,8.1,99.04,3.24,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,16.3,95.62,2.09,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,32.7,92.01,2.66,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,68.2,76.8,8.75,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,136.4,28.13,3.99,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Colon,HT-29,72,Umbelliprenin,272.8,10.83,2.66,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,8.1,100,6.89,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,16.3,97.82,4.72,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,32.7,98.91,4.17,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,68.2,59.52,6.17,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,136.4,41.74,1.99,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,24,Umbelliprenin,272.8,20.14,1.81,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,8.1,98.91,7.98,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,16.3,98,7.98,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,32.7,93.1,2.35,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,68.2,64.79,1.81,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,136.4,30.82,1.6,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,48,Umbelliprenin,272.8,16.87,1.99,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,8.1,98.18,8.89,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,16.3,96.37,9.8,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,32.7,94.55,9.8,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,68.2,89.83,6.89,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,136.4,53.72,4.17,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Breast,MCF-7,72,Umbelliprenin,272.8,17.96,2.9,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,8.5,96.54,7.56,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,17,98.28,2.58,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,34,93.02,1.84,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,68.2,71.52,5.37,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,136.4,46.71,11.07,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,24,Umbelliprenin,272.8,23.55,3.5,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,8.5,100.96,4.24,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,17,96.99,6.08,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,34,90.62,7.56,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,68.2,71.15,5.9,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,136.4,32.05,2.58,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,48,Umbelliprenin,272.8,10.44,2.02,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,8.5,98.19,10.7,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,17,93.49,7.19,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,34,89.7,11.07,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,68.2,68.57,10.15,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,136.4,41.91,3.32,3,100,2.29,3 | |
| 39,Rashidi et al.,2016,Glioma,A172,72,Umbelliprenin,272.8,17.83,2.76,3,100,2.29,3 | |
| 43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,48,Umbelliprenin,20,99.8,4.8,3,99.9,1.96,3 | |
| 43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,48,Umbelliprenin,40,99.9,4.8,3,99.9,1.96,3 | |
| 43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,48,Umbelliprenin,80,74.9,3.77,3,99.9,1.96,3 | |
| 43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,72,Umbelliprenin,20,99.09,1.51,3,99.39,1.51,3 | |
| 43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,72,Umbelliprenin,40,95.79,4.27,3,99.39,1.51,3 | |
| 43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,72,Umbelliprenin,80,60.06,12.61,3,99.39,1.51,3 | |
| 43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,96,Umbelliprenin,1,87.08,14.42,3,98.79,2.41,3 | |
| 43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,96,Umbelliprenin,40,75.67,24.63,3,98.79,2.41,3 | |
| 43,Goodarzi et al.,2022,Leukemia/Lymphoma,MT-2,96,Umbelliprenin,80,60.06,4.8,3,98.79,2.41,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,6.25,95.66,1.45,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,12.5,93.85,1.09,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,25,85.51,1.08,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,50,76.82,5.8,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,100,56.89,2.17,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,24,Umbelliprenin,200,23.56,1.82,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,6.25,95.29,2.53,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,12.5,92.76,1.45,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,25,81.53,2.54,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,50,70.29,2.53,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,100,33.34,1.09,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,48,Umbelliprenin,200,7.06,1.26,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,6.25,81.53,2.54,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,12.5,75.73,1.81,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,25,69.93,2.17,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,50,53.99,2.9,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,100,36.96,2.9,3,100,2.29,3 | |
| 54,Hamidinia et al.,2013,Colon,SW48,72,Umbelliprenin,200,4.35,1.45,3,100,2.29,3 | |
| 55,Ziai et al.,2012,Leukemia,Jurkat T,16,Umbelliprenin,10,92.47,1.94,3,100,2.29,3 | |
| 55,Ziai et al.,2012,Leukemia,Jurkat T,16,Umbelliprenin,25,86.15,3.65,3,100,2.29,3 | |
| 55,Ziai et al.,2012,Leukemia,Jurkat T,16,Umbelliprenin,50,63.06,2.92,3,100,2.29,3 | |
| 55,Ziai et al.,2012,Leukemia,Jurkat T,16,Umbelliprenin,100,39.73,2.43,3,100,2.29,3 | |
| 55,Ziai et al.,2012,Leukemia,Jurkat T,48,Umbelliprenin,10,69.18,2.74,3,100,2.29,3 | |
| 55,Ziai et al.,2012,Leukemia,Jurkat T,48,Umbelliprenin,25,50.35,3.43,3,100,2.29,3 | |
| 55,Ziai et al.,2012,Leukemia,Jurkat T,48,Umbelliprenin,50,25.69,3.08,3,100,2.29,3 | |
| 55,Ziai et al.,2012,Leukemia,Jurkat T,48,Umbelliprenin,100,13.7,3.42,3,100,2.29,3 | |
| 56,Barthomeuf et al.,2008,Colon,DLD1,48,Umbelliprenin,27.3,70.98,4.02,3,100,2.29,3 | |
| 56,Barthomeuf et al.,2008,Breast,MCF-7,48,Umbelliprenin,27.3,62.67,3.68,3,100,2.29,3 | |
| 56,Barthomeuf et al.,2008,Ovarian,PA1,48,Umbelliprenin,27.3,55.04,3.67,3,100,2.29,3 | |
| 56,Barthomeuf et al.,2008,Melanoma,M4Beu,48,Umbelliprenin,27.3,3.66,1.84,3,100,2.29,3 | |
| 56,Barthomeuf et al.,2008,Prostate,PC3,48,Umbelliprenin,27.3,38.07,3.21,3,100,2.29,3 | |
| 56,Barthomeuf et al.,2008,Lung,A549,48,Umbelliprenin,27.3,41.01,3.22,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,20,77.04,2.46,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,40,65.3,2.45,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,60,54.09,1.1,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,80,42.89,2.19,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,100,34.15,1.09,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,120,26.77,1.37,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,24,Umbelliprenin,140,19.39,2.19,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,20,67.87,1.33,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,40,47.15,1.55,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,60,38.08,0.8,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,80,36.01,1.03,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,100,31.86,1.55,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,120,21.5,1.81,3,100,2.29,3 | |
| 57,Kamalkazemi et al.,2023,Colon,HT-29,48,Umbelliprenin,140,14.24,1.56,3,100,2.29,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,24,Umbelliprenin,3.13,83.33,5.72,3,99.5,2.49,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,48,Umbelliprenin,3.13,72.13,1.5,3,100,1,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,72,Umbelliprenin,3.13,66.16,3.98,3,99.25,2.24,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,24,Umbelliprenin,6.25,63.68,2.73,3,99.5,2.49,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,48,Umbelliprenin,6.25,54.71,2.5,3,100,1,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,72,Umbelliprenin,6.25,52.83,4.04,3,99.25,2.24,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,24,Umbelliprenin,12.5,34.82,3.73,3,99.5,2.49,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,48,Umbelliprenin,12.5,32.58,2.74,3,100,1,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,72,Umbelliprenin,12.5,30.09,5.48,3,99.25,2.24,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,24,Umbelliprenin,25,24.37,1.99,3,99.5,2.49,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,48,Umbelliprenin,25,22.13,6.97,3,100,1,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,72,Umbelliprenin,25,20.14,2.99,3,99.25,2.24,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,24,Umbelliprenin,50,14.67,2.49,3,99.5,2.49,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,48,Umbelliprenin,50,12.68,2.24,3,100,1,3 | |
| 58,Zhang et al.,2019,Gastric,AGS,72,Umbelliprenin,50,10.19,3.98,3,99.25,2.24,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,24,Umbelliprenin,3.13,89.61,5.55,3,99.51,2.42,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,48,Umbelliprenin,3.13,83.81,1.69,3,100,1.29,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,72,Umbelliprenin,3.13,77.29,4.11,3,99.51,2.18,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,24,Umbelliprenin,6.25,74.39,3.14,3,99.51,2.42,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,48,Umbelliprenin,6.25,71.98,2.41,3,100,1.29,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,72,Umbelliprenin,6.25,63.52,3.87,3,99.51,2.18,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,24,Umbelliprenin,12.5,67.87,3.86,3,99.51,2.42,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,48,Umbelliprenin,12.5,60.86,2.42,3,100,1.29,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,72,Umbelliprenin,12.5,60.86,6.28,3,99.51,2.18,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,24,Umbelliprenin,25,44.92,1.45,3,99.51,2.42,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,48,Umbelliprenin,25,42.59,6.68,3,100,1.29,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,72,Umbelliprenin,25,40.09,3.14,3,99.51,2.18,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,24,Umbelliprenin,50,24.87,2.18,3,99.51,2.42,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,48,Umbelliprenin,50,23.07,2.77,3,100,1.29,3 | |
| 58,Zhang et al.,2019,Gastric,BGC-823,72,Umbelliprenin,50,15.45,3.87,3,99.51,2.18,3 | |
| 61,Gkionis et al.,2021,Breast,MCF-7,48,Umbelliprenin,98,50,5.61,2,100,2.29,2 | |
| 61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,88,50,5.61,2,100,2.29,2 | |
| 61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,0.1,99.68,5.61,2,100,2.29,2 | |
| 61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,1,89.71,14.65,2,100,2.29,2 | |
| 61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,10,101.55,4.05,2,100,2.29,2 | |
| 61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,50,95.01,6.54,2,100,2.29,2 | |
| 61,Gkionis et al.,2021,Breast,MDA-MB231,48,Umbelliprenin,100,40.8,3.74,2,100,2.29,2 | |
| 67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,13.67,50,2.28,3,100,1.72,3 | |
| 67,Zhang et al.,2015,Cervical,HeLa,24,Umbelliprenin,75.83,50,2.28,3,100,1.72,3 | |
| 67,Zhang et al.,2015,Lung,A549,24,Umbelliprenin,121.53,50,2.28,3,100,1.72,3 | |
| 67,Zhang et al.,2015,Prostate,PC3,24,Umbelliprenin,88.27,50,2.28,3,100,1.72,3 | |
| 67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,6.25,87.72,1.43,3,97.72,1.72,3 | |
| 67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,12.5,80.86,2.28,3,97.72,1.72,3 | |
| 67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,25,71.43,2.57,3,97.72,1.72,3 | |
| 67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,50,48,7.14,3,97.72,1.72,3 | |
| 67,Zhang et al.,2015,Gastric,AGS,24,Umbelliprenin,100,20,2,3,97.72,1.72,3 |